Scaling Dementia Care Across a Health System: Integrating Biomarkers, Decision Support, and Collaborative Care Models

Abstract

Background: Blood‐based biomarkers (e.g., ptau217) and anti‐amyloid therapies have increased the need for earlier, systematic dementia detection in primary care. However, PCPs often lack the tools, training, and time to incorporate these innovations into routine practice.

The paper